Building Success
When it comes to Effective HIV reform, don’t throw the baby out with the bathwater
by Mariel Selbovitz, MPH, and Leslie G Selbovitz, MD
LifeGuide
Extensive progress in…
Speed Test
An antigen and antibody combo assay zeroes in on acute infection
Treatment Horizons by Chael Needle
The diagnosis of acute HIV infection, when the virus is…
SMYD2 & the HIV Reservoir
Shock Value
Research on SMYD2 shows potential to wake up the HIV reservoir
by Chael Needle
HIV latency—where HIV hides out in reservoirs, dormant and beyond the…
Treatment as Prevention
LifeGuide
A community perspective on PrEP delves into its pros & cons
by Jeannie Gibbs
Post-exposure prophylaxis (PrEP) is the provision of antiretrovirals (ARVs) to HIV-negative…
Alisson Sombredero, MD
Not So Complicated
Alisson Sombredero, MD, offers to physicians compelling approaches to HIV care
by Chael Needle
Alisson Sombredero, MD, is more than two months into her…
HIV Latency & HDACs
Hide and Seek
Led by Dr. Daria Hazuda, researchers tackle HIV latency with HDAC inhibitors
by Chael Needle
With all the talk around viral suppression, it may…
Protecting the Pipeline
LifeGuide
HIV drug development faces challenges
by Jeannie Wraight and Mariel Selbovitz, MPH
Triple and now quad drugs like Gilead’s Atripla and their new compound known…
REPRIEVE Study
Protecting One’s Heart
The REPRIEVE study aims to prevent cardiovascular disease
by Chael Needle
As people are living longer with HIV, researchers have been increasingly attending to…
New Nukes, Old Nukes
Nuclear Waste
How to get overwhelmed by the data on new nukes, old nukes & lots of
different classes of ART at AIDS 2014
by Mariel…
PRO 140
Chronic Relief?
A self-injectable monoclonal antibody vies to become a monotherapy
by Chael Needle
Anti-HIV agents currently being researched these days seem split between (1) improving regimens…
LATEST POSTS
Just*in Time: June 2017
Hey Justin,
I know you talk about HIV most of the time and sometimes I would wish you’d talk about something else. So, I figured…
